---
title: "Hezong Medicine Easy-To-Buy Pharmaceutical: Net profit loss of 742,100 yuan in the third quarter, a decrease of 140.42%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/262425785.md"
description: "Hezong Medicine Easy-To-Buy Pharmaceutical announced that its revenue for the third quarter was 1.085 billion yuan, a year-on-year increase of 7.41%; net profit loss was 742,100 yuan, a decrease of 140.42%. Revenue for the first three quarters was 3.242 billion yuan, a year-on-year increase of 0.21%; net profit loss was 8.3565 million yuan, a decrease of 159.98%"
datetime: "2025-10-23T11:49:28.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/262425785.md)
  - [en](https://longbridge.com/en/news/262425785.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/262425785.md)
---

# Hezong Medicine Easy-To-Buy Pharmaceutical: Net profit loss of 742,100 yuan in the third quarter, a decrease of 140.42%

Hezong Medicine Easy-To-Buy Pharmaceutical announced that its revenue for the third quarter was 1.085 billion yuan, an increase of 7.41% year-on-year; the net profit loss was 742,100 yuan, a decrease of 140.42%. Revenue for the first three quarters was 3.242 billion yuan, an increase of 0.21% year-on-year; the net profit loss was 8.3565 million yuan, a decrease of 159.98%

### Related Stocks

- [300937.CN](https://longbridge.com/en/quote/300937.CN.md)

## Related News & Research

- [11:23 ETTOUS les JOURS BRINGS OFFICIAL BTS THE CITY ARIRANG POP-UP EXPERIENCE TO LAS VEGAS BAKERY CAFÉS](https://longbridge.com/en/news/286793282.md)
- [17:39 ETEVA Air Wins SKYTRAX 5-Star Airline Certification 11th Year in a Row](https://longbridge.com/en/news/286822574.md)
- [ZAWYA: Joramco supports Tawasol 2026, reaffirming its commitment to empowering Jordanian youth](https://longbridge.com/en/news/286925638.md)
- [09:15 ETNewport Healthcare's 2025 Outcomes Report Demonstrates Significant Improvements in Teen and Young Adult Mental Health Following Treatment](https://longbridge.com/en/news/286920260.md)
- [00:45 ETAraceli Biosciences Launches Endeavor® Live Cell for Ultra-High-Throughput Kinetic Imaging in AI-Driven Drug Discovery](https://longbridge.com/en/news/287006505.md)